Clinical Trials Directory

Trials / Completed

CompletedNCT01004107

Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation

Phase 4, Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Merz North America, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.

Detailed description

This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment. This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment, comprised of a 3-month main study followed by an open-label extension (OLEX) study through 12 months. At 3 months, untreated controls received Radiesse Dermal Filler for hand treatment and were followed for the remainder of the study. All study subjects were eligible for retreatment 6 months after initial treatment, and all subjects were followed through 12 months from study enrollment in the OLEX.

Conditions

Interventions

TypeNameDescription
DEVICERadiesse Injectable Dermal FillerCalcium hydroxylapatite particles suspended in an aqueous-based gel carrier

Timeline

Start date
2008-10-01
Primary completion
2010-03-01
Completion
2010-04-01
First posted
2009-10-29
Last updated
2018-07-13
Results posted
2018-07-13

Locations

4 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01004107. Inclusion in this directory is not an endorsement.